<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07290019059400</udiDi>
    <basicUdiDi>7290019059CS100TQ</basicUdiDi>
    <tradeName>CureSight</tradeName>
    <deviceName>CureSight</deviceName>
    <manufacturerName>NovaSight Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000011872</manufacturerSrn>
    <authorisedRepresentativeName>MedNet EC-REP GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000002</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120204</emdnCode>
    <emdnDescription>SYNOPTISCOPES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NSP-000200</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-02T22:23:27.935Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904343700103</udiDi>
    <basicUdiDi>89043437SYNO/ASPK7</basicUdiDi>
    <tradeName>Appasamy</tradeName>
    <deviceName>Appa Synoptophore</deviceName>
    <manufacturerName>Appasamy Associates Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000012093</manufacturerSrn>
    <authorisedRepresentativeName>Amstermed B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000001971</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120204</emdnCode>
    <emdnDescription>SYNOPTISCOPES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ASP 902</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T07:49:17.844Z</lastUpdated>
  </row>
</eudamedExport>